Benefits of regular physical activity on Doxorubicin-induced Kidney Toxicity by Daniela Filipa Cardoso
I 
 
 
 
 
 
Universidade do Porto 
Faculdade de Desporto 
 
 
Benefits of Regular Physical Activity on 
Doxorubicin-induced Kidney Toxicity  
 
 
 
Dissertação apresentada com vista à 
obtenção do grau de mestre em 
Atividade Física e Saúde, da Faculdade 
de Desporto da Universidade do Porto 
ao abrigo do Decreto Lei nº.74/2006 de 
24 de março, orientada pelo Professor 
Doutor José Alberto Ramos Duarte 
(Professor Catedrático da Faculdade de 
Desporto da Universidade do Porto). 
 
 
 
 
 
Daniela Filipa Cardoso 
 
Porto, 2017 
 
II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardoso, D. (2017). Benefits of Regular Physical Activity on Doxorubicin-induced 
Kidney Toxicity. Porto: D. Cardoso. Dissertação apresentada às provas para 
obtenção do grau de Mestre em Atividade Física e Saúde, apresentada à 
Faculdade de Desporto da Universidade do Porto, Porto. 
 
Key words: Physical Activity, Cancer, Doxorubicin, Kidney, Toxicity, Renal 
Damage, Bowman’s Capsule Thickness, Collagen.   
III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To my father  
IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V 
 
Acknowledgments 
 
The realization of this work would not have been possible without the 
collaboration of several people. Fortunately, I was surrounded by people who 
gave me their contributions, which allowed me to stay motivated and focused on 
my work. So, I would like to thank everyone for taking their time to help me.  
Firstly, I would like to thank my supervisor, Professor Doutor José Alberto Ramos 
Duarte, for receiving me and for allowing me to join his amazing team and lab. 
During this year, I could learn a lot with the professor, which helped me grow and 
improve my knowledge. I am very grateful and it was a good pleasure working 
with my supervisor during this year. The professor is an example for me that I 
want to follow. Thank you for the opportunity, the comprehension, the dedication 
to my work and, especially, for you believe in my work and teach me every day.  
To Dona Celeste for receiving and helping me with all laboratory procedures. 
Thank you, for the fellowship and the many hours spent with my work.  
To my laboratory colleagues, Daniel, Hélder, Tóni, Júlio, Nilton, Camila, Paulo, 
Ana Padrão, Cris and Fernando for supporting me and teach me during this time. 
Thank you all, for the motivation and for you calm me down in the right moments.  
To my best friends Rita, Marisa, Miguel, Flávio, Pedro and Melissa for helping me 
and believe in me. I’m grateful for our friendship and for the support that all of you 
gave me during this year.   
To Rodrigo, thank you for your presence and motivation. Thank you for you 
appearing in my life. You were my greatest strength that gave me motivation to 
finish my work. Thank you for believing and supporting me. 
To my mother, thank you for you trust and believe in me. I am so proud for having 
you as a mother.  
 
Finally, I wish to give a special thank, 
 
….to my hero, a special thank you to you father. Every day you were in my mind. 
Thank you, for you taught me to be who I am, for all moments spend with you, for 
your words and for you believe in me, in my capacity. I did my thesis for you. You 
VI 
 
were the reason that made me wake up every day and went to work, because I 
want to be like you intelligent, hardworking, seek knowledge and sharing this 
knowledge. Thank you for you making me a good student and a lucky daughter. 
I want to dedicate all my work to you, I know that you are here seeing me and 
smiling for me.  Love you so much Father! 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VII 
 
Index of Contents 
 
Acknowledgments .............................................................................................. V 
Index of Contents ............................................................................................. VII 
Index of figures .................................................................................................. IX 
Index of tables ................................................................................................... XI 
Resumo ........................................................................................................... XIII 
Abstract ........................................................................................................... XV 
List of Abbreviations ...................................................................................... XVII 
1. General introduction ....................................................................................... 1 
1.1. Structure of the dissertation ..................................................................... 4 
2. State of the art ................................................................................................ 7 
2.1. Pharmacokinetics and pharmacodynamics of doxorubicin ............... 8 
2.2. DOX-induce side-effects ................................................................... 9 
       2.2.1. Side-effects on kidneys ......................................................... 10 
2.3. The benefits of physical exercise practice before, during and ........ 11 
after DOX treatment ............................................................................... 11 
3. Experimental Article ..................................................................................... 15 
4. Main Conclusions ......................................................................................... 34 
5. References ................................................................................................... 35 
 
 
  
VIII 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IX 
 
Index of figures 
 
Figure 1: Experimental design. ........................................................................ 19 
Figure 2: Representative photomicrographs stained with hematoxylin and eosin 
of kidneys from group sterile saline solution (SSSG), group sterile saline solution 
sedentary (SSSsedG), group sterile saline solution active (SSSactG), group 
doxorubicin (DOXG), group doxorubicin sedentary (DOXsedG), and group 
doxorubicin active (DOXactG). On DOXG a large amount of necrotic cells was 
verified; interstitial edema was observed on DOXsedG and DOXactG; and tubular 
dilatation with hyaline deposition on DOXsedG. ............................................... 31 
Figure 3: Representative photomicrographs stained with hematoxylin and eosin 
of kidneys from group sterile saline solution (SSSG), group sterile saline solution 
sedentary (SSSsedG), group sterile saline solution active (SSSactG), group 
doxorubicin (DOXG), group doxorubicin sedentary (DOXsedG), and group 
doxorubicin active (DOXactG). On DOXG was verified the existence of edema 
(Yellow arrow) and vacuolated cells (Black arrow).  A deposition of hyaline (Black 
arrow), a distal tubular dilatation (Red arrow) and conjunctive tissue (White arrow) 
was observed on DOXsedG. In DOXactG the hyaline content in tubules (Black 
arrow) was less than the last group, while were also found tubular dilatation (Red 
arrow). It is noted the conjunctive tissue around the tubules (White arrow) and 
vascular congestion (Yellow arrow). ................................................................. 32 
Figure 4: Values (presented as mean±standard deviation) of the percentage of 
total collagen deposition in kidney area in group sterile saline solution (SSSG), 
group sterile saline solution sedentary (SSSsedG), group sterile saline solution 
active (SSSactG), group doxorubicin (DOXG), group doxorubicin sedentary 
(DOXsedG), and group doxorubicin active (DOXactG). ................................... 33 
Figure 5: Values (presented by mean standard deviation) of thickness of the 
Bowman’s capsules of the kidneys in group sterile saline solution (SSSG), group 
sterile saline solution sedentary (SSSsedG), group sterile saline solution active 
(SSSactG), group doxorubicin (DOXG), group doxorubicin sedentary 
(DOXsedG), and group doxorubicin active (DOXactG). ................................... 33 
 
X 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XI 
 
Index of tables 
 
Table 1: Values (presented as mean±standard deviation) of body weight and 
kidney absolute and relative weight from all groups, and total running distance 
performed by active groups. ............................................................................. 30 
Table 2: Values (presented as a Median (Interquartile Range)) of histologic 
alterations used to assess kidney damage in all groups. ................................. 30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XII 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XIII 
 
Resumo 
 
A doxorrubicina (DOX), antraciclina usada na quimioterapia no tratamento de 
diversos cancros, encontra-se associada a vários efeitos colaterais, 
nomeadamente, à toxicidade induzida nos mais diversos tecidos em doentes 
oncológicos e/ou sobreviventes. O dano renal, o aumento da espessura da 
cápsula de Bowman (ECB) e a deposição de colágeno nos rins, são alguns dos 
efeitos adversos associados à diminuição da função renal. No entanto, a 
atividade física regular poderá ser utilizada como um recurso não farmacológico 
e terapêutico para a diminuição desses efeitos, tanto em humanos como em 
animais. Alguns estudos têm vindo demonstrar os benefícios da prática regular 
de exercício físico na diminuição da toxicidade renal em ratos saudáveis, 
nomeadamente nos parâmetros referidos anteriormente, no dano renal, na 
deposição de colagénio e na espessura da capsula de Bowman. O objetivo deste 
trabalho foi verificar a toxicidade e os mecanismos subjacentes à DOX; e se a 
prática de exercício físico poderia ser capaz de reverter a toxicidade renal 
induzida pela prolongada administração da DOX, imitando um protocolo de 
quimioterapia, em ratos saudáveis. Trinta e quatro ratos Wistar machos foram 
divididos aleatoriamente em 2 clusters: 1) tratado com DOX (DOX, n=17) 
semanalmente com uma injeção intraperitoneal (i.p) de 2 mg/kg de DOX durante 
7 semanas e 2) tratado com solução salina estéril (SSS, n=17) com a 
administração semanal de uma injeção i.p de veiculo durante 7 semanas. Duas 
semanas após a última injeção, 5 animais de cada grupo (SSSG, n=5; DOXG, 
n=5) foram sacrificados e os restantes divididos em subgrupos: sedentários 
(DOXsedG, n=6; SSSsedG, n=6) e ativos (DOXactG, n=6; SSSactG, n=6). 
Ambos os subgrupos foram colocados individualmente numa jaula durante 2 
meses. A jaula dos animais ativos estava equipada com uma roda de aço. No 
final do protocolo, os animais foram sacrificados e os rins foram analisados 
histologicamente. Os resultados relevaram que os rins dos animais tratados com 
DOX obtiveram maiores níveis de dano, de deposição de colagénio e um 
aumento da ECB a curto prazo quando comparado com o SSSG group (p<.05). 
Por outro lado, a longo prazo nos animais do DOXsedG apenas se verificou 
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maior dano e um aumento da ECB relativamente ao DOXG group (p<.05). 
Enquanto que, no grupo ativo com DOX, o dano renal, a deposição de colagénio 
e a ECB diminuíram relativamente ao grupo DOXsedG (p<.05). Em suma, a 
corrida voluntária de forma regular, parece melhorar e atenuar os efeitos 
colaterais renais em ratos saudáveis após um tratamento quimiotático 
prolongado. 
 
Palavras-chave: Atividade física, Cancro, Doxorrubicina, Rim, Toxicidade, Dano 
renal, Espessura da cápsula de Bowman, Colagénio 
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Abstract 
 
Doxorubicin (DOX), an anthracycline used in cancer treatments, has a lot of side-
effects, such us the capacity for induce high levels of toxicity on tissues and 
organs of patients and cancer survivors. Renal damage, increasing collagen 
deposition and the thickness of Bowman’s capsule (TBC) are some side-effects 
which occur after a chemotactic treatment, and most of them are connected with 
renal dysfunction and failure. However, it is well documented that regular physical 
activity is important to reduce the side-effects, and could be used as a therapy 
improving renal structure and function on rats and humans. Several studies have 
verified the benefit effects of regular exercise practice on the reduction of kidney 
toxicity in healthy rats, decreasing their levels of damage, collagen content and 
also decrease the thickness of bowman’s capsule. The aim of this study was to 
understand the mechanisms underlying DOX-induce kidney toxicity and verify if 
physical exercise practice could be used to improve and revert these side-effects 
caused by a prolonged DOX administration on healthy rats. Thirty-four male 
Wistar rats were randomly divided into 2 clusters: 1) one treated with doxorubicin 
(DOX, n=17), which received weekly an intraperitoneal (i.p.) injection of 2 mg/kg 
of DOX for 7 weeks, and 2) the other treated with sterile saline solution (SSS, 
n=17) that received i.p. injections of vehicle during 7 weeks. Two weeks after the 
last injection, five animals from each group (SSSG, n=5; DOXG, n=5) were 
euthanized while the remaining rats were subsequently divided into sedentary 
(DOXsedG, n=6; SSSsedG, n=6) and active subgroups (DOXactG, n=6; 
SSSactG, n=6). Both groups were placed individually in cages during 2 months, 
however the cages of active animals were equipped with a run wheel for voluntary 
running. At the end of the protocol, animals were euthanized and kidneys were 
histologically examined. The results revealed higher levels of renal damage, 
collagen deposition and an increase of TBC at short-term, on DOXG animals 
comparatively with SSSG group (p<.05). While, at long-term it was observed 
higher levels of damage and an increase of TBC (p<.05). However, the collagen 
content remain similar between DOXG and DOXsedG groups.  On active group, 
compared with DOXsedG, a decreased of renal damage, collagen content and 
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the TBC (p<.05) was observed. These results allow concluding that regular 
voluntary running, applied after a prolonged DOX administration, is effective to 
attenuate the harmful effects of this drug in kidneys.  
 
KeyWords: Physical Activity, Cancer, Doxorubicin, Kidney, Toxicity, Renal 
Damage, Bowman’s Capsule Thickness, Collagen.   
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1. General introduction 
 
Cancer is a large group of diseases which is characterized by an uncontrollable 
proliferation and differentiation of cells process in any part of the body; then these 
abnormal cells can disseminating all over the body, creating metastasis 
(Stevinson et al., 2016; World Health Organization, 2015). The prevalence of 
cancer has been growing and in 2012 there were 14.1 million new cases of 
cancer and 8.2 million deaths (Cancer Research UK, 2014). In the next two 
decades, it is expected a 70% growth in cancer cases (World Health 
Organization, 2015). More precisely in 2025, 19.3 million new cases per year are 
expected (Centers for disease control and prevention, 2016). In children, to 15 
years old, the incidence of cancer varies between 0.5% and 4.6% of all types of 
cancer and the incidence rate varies between 50 to 200 million worldwide (IARC 
World Cancer Report, 2014). These numbers point out to the undeniable 
importance of studying, not only prevention but also detection and treatment. 
Indeed, advances in early detection and in cancer treatments led to a substantial 
increase in the number of oncological survivors over the last 20 years (Vijayvergia 
& Denlinger, 2015). In addition, around 60% of individuals with cancer, live more 
than 5 years after the diagnosis of their disease (Buffart & May, 2014), which 
further underlies the importance of studying mechanisms through which life 
quality can be increased. 
Despite the availability of a series of cancer treatments (World Health 
Organization, 2003), the majority of patients also do chemotherapy (Schmitz et 
al., 2010). This method is used since 1943 (World Health Organization, 2003). 
One of the drugs administered during chemotherapy is DOX which is an ANT 
antibiotic (Chabner et al., 2001). ANT have been used in the treatment of 
malignant neoplasms such us leukemia and solid tumors (Lipshultz et al., 2014). 
The treatment using DOX was established in 1960 (Arcamone et al., 1969) and 
since then it is considered one of the most efficient methods for treating 
oncological diseases (Moylan, 2015). As a case in point, it is estimated that more 
than 50% of childhood survivors had received treatments with ANT’s (Sterba et 
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al., 2013) and after the introduction of DOX in treatments the 5-year survivor rate 
among children increased approximately to 80% (Ward et al., 2014).  
However, in spite of its efficiency in treating cancer itself, DOX has as important 
side-effects. In other words, the problem is not the treatment itself but the toxic 
side-effects that it can cause (Ayla et al., 2011). The present research is 
especially interested in this aspect of DOX treatments. We will therefore now 
focus on the main side-effects associated with cancer treatments involving DOX. 
One of the most commonly known side-effects of DOX is the induction of high 
levels of cardiotoxicity both in adults and children (Franco & Lipshultz, 2015; 
Lustberg & Zareba, 2016) that have led to a limited clinical use of this drug 
(Carvalho et al., 2009). Depending on the dosage, DOX can induce a progressive 
cardiac damage manifesting itself in decreased ejection fraction of the left 
ventricle, heart failure (Scott et al., 2011) and myocardial infarction (Franco & 
Lipshultz, 2015). DOX is also known for causing pulmonary, testicular and 
hematological toxicity, among other damages (Ayla et al., 2011). Importantly for 
our purpose, DOX has been reported to cause a series of damaging effects at 
the kidney level and this is going to be the focus of the present research.  
Firstly, by increasing nephrotoxicity, DOX is known to create glomerular capillary 
permeability and tubular atrophy (Ayla et al., 2011; El-Sheikh et al., 2012; Jadhav 
et al., 2013; Mustafa et al., 2015). Moreover, DOX is responsible for the triggering 
of an oxidative stress on rat kidneys (Mokni et al., 2016) and can also increase 
the glomerular volume and induce renal edema (Peng et al., 2012a). 
Furthermore, the use of this drug has been associated with renal dysfunction. 
Indeed, histological analyses show glomerular and tubule-interstitial damage 
(Elsherbiny & El-Sherbiny, 2014). Among animals treated with DOX, there was a 
glomeruli distortion, vascular congestion, tubules focal atrophy necrosis and 
exfoliation and the filtration space obliterated disappeared (Su et al., 2015). The 
percentage of collagen increased in the kidneys of rats treated with DOX 
compared with rats that have not received this drug (Egger et al., 2015). This 
deposition happens in the renal interstitial tissue and in the renal cortex (Peng et 
al., 2012a; Peng et al., 2012b). Of special relevance for the goal of the present 
research, the renal injuries found in rats treated with DOX are extremely similar 
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to the ones found in humans with chronic kidney disease, and this mainly 
because of the development of primary focal segmental glomerulosclerosis (Lee 
& Harris, 2011).  
Given the (unfortunate) large list of side-effects of DOX treatments, we aim at 
looking at factors that might help to minimize the detrimental impact of this drug 
on the body, and specifically on the kidney functions. Among these factors, we 
can find physical activity. Nowadays it is unquestionable that regular physical 
exercise (RPE) is paramount in decreasing the risk of obesity, cardiovascular 
diseases, premature mortality and morbidity related to chronic diseases (Kummer 
et al., 2013; West et al., 2014). Importantly, the psychological and physical 
benefits of RPE have been extended to cancer survivors (Kummer et al., 2013; 
Wang et al., 2015). There is evidence that physical exercise could be an option 
to buffer the side-effects felt by the cancer survivors (Scott et al., 2011). 
Specifically, and importantly for the goals of the present research, the benefits of 
physical exercise are well documented on the acute and chronic cardiotoxicity 
effects caused by DOX described above (Hayward et al., 2012; Lien et al., 2015). 
There is also some evidence showing that endurance training can reduce DOX 
cardiotoxicity in individuals with cancer (Hydock et al., 2012). In addition, doing 
RPE can help in the process of cell survival, proliferation and growth in chronic 
kidney disease cases induced by DOX (Peng et al., 2012b). Furthermore, 60 
minutes of swimming seems to restore the renal edema status and to improve 
collagen deposition after a singles injection of DOX (Peng et al., 2012a). 
Relatedly, aerobic exercise has improved the nitrite and serum urea levels in 
renal structure decreased damage in the kidney tissue and increased the 
activation of the oxidant system among patients being treated with Cisplatin, 
(Zeynali et al., 2015). Cisplatin is considered a drug belonging to the platinum 
classes, even if it is not an ANT like DOX, cisplatin is one of the drugs used in 
chemotherapy treatments, which one of the most important side effects is 
nephrotoxicity (such as DOX) (Hanigan & Devarajan, 2003).  
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Goals of the present thesis 
The main goals of the present study are: 1) to better understand the mechanisms 
underlying the side-effects induced by DOX and; 2) to examine the role of regular 
voluntary running as a non-pharmacological therapy in minimizing the side-
effects on kidney structure of animals exposed to chemotactic treatments 
involving the administration of DOX. Given the lack of research addressing the 
role of physical activity in buffering the detrimental effects of DOX therapy, our 
first goal is going to be addressed by a more in-depth review of the literature. This 
review will focus on the one hand, on the role of physical activity in cancer patients 
and in animal models treated with drugs similar to DOX and, on the other hand 
on the specific effects of DOX on cancer patients’ kidneys as well as in rats. This 
approach will allow us to have a clearer picture of the state of the art of research 
on both domains and therefore to elaborate a more informed hypothesis for the 
experimental study that will follow. In this study, the main goal is to advance 
knowledge concerning the specific toxic effects of DOX on the kidney structure 
and understand the benefits of voluntary running on rats treated with DOX.  
Lastly, in the current study is expected an increase of renal damage, collagen 
deposition and the TBC on kidney structure of sedentary rats treated with DOX, 
even at short and long-term. However, it is supposed that regular voluntary 
running will ameliorate kidney function and structure decreasing their damage, 
collagen deposition and the TBC.  
 
1.1. Structure of the dissertation  
 
This dissertation is according to the Scandinavian Model and it is divided into four 
sections: 
Section 1: This chapter has the general introduction, the main goals, also the 
importance of this study and the structure of the dissertation. 
Section 2: This is composed of a state of the art about “Potential mechanisms of 
kidney toxicity induced by doxorubicin and the benefit effects of regular exercise 
as a therapy in the renal toxicity”. 
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Section 3: This chapter is an experimental study: “Favorable effects of regular 
voluntary running on kidney toxicity induced by doxorubicin in Wistar rats”.   
Section 4: In this chapter are presented the main conclusions of this dissertation.  
Section 5: Lastly, in this section are present the references. 
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2. State of the art 
 
Among other treatments, chemotherapy is one of the most used treatment in a 
wide oncological diseases cases (Schmitz et al., 2010). This type of treatment 
could be composed of a variety of chemotactic agents, which are classified into 
several classes: antimetabolites, alkylating agents, platinum derivates, 
anthracyclines and like agents, and natural alkaloids (World Health Organization, 
2003).  
Anthracyclines (ANTs) are considered antineoplastic antibiotics introduced in 
clinical practice (Simunek et al., 2009), which increased the success of 
treatments on cancer survivors (Štěrba et al., 2013). Doxorubicin (DOX), 
commercially known as Adriamycin, is an antineoplastic drug belonging to the 
ANT’s group, used in combination with other drugs in chemotherapy for cancer 
treatment in both adults and children (Cancer Research UK, 2015; Injac & 
Strukelj, 2008; Lustberg & Zareba, 2016; Saffi et al., 2010). DOX (C27H29NO11) is 
composed by a quinone and hydroquinone, a carbonyl group at C-13 and a C-14 
hydroxyl group, also an amino-sugar daunosamine attached by a glycosidic bond 
to the C-7 on the tetracyclic ring (Štěrba et al., 2013). In 1960, DOX was isolated 
from cultures of S. peucetius var. caesius., a species of actinobacteria (Simunek 
et al., 2009; Štěrba et al., 2013) and is the hydroxylated congener of daunorubicin 
(daunomycin) (Gewirtz, 1999). Since then, is considered one of the most efficient 
drugs in the treatment of oncological diseases (Moylan, 2015; Štěrba et al., 
2013). Over the years, DOX has been mainly used to treat a variety of cancers 
such as leukemia’s, lymphomas (Hodgkin and Non-Hodgkin), multiple myeloma, 
sarcoma, as well as ovarian, thyroid, breast, lung, gastric, and pediatric cancers 
(Das et al., 2016; Shi et al., 2011). 
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2.1. Pharmacokinetics and pharmacodynamics of doxorubicin 
 
Pharmacokinetic of DOX diverge among humans and animals (Lee & Harris, 
2011). In humans, DOX is predominantly metabolized in the liver to the major 
metabolite, doxorubicinol, having a quick distribution and a slow elimination. 
Approximately 40-50% of DOX is eliminated in seven days mostly through the 
bile and around 4-5% is excreted in the urine in five days (Lee & Harris, 2011; 
Robert & Gianni, 1993). On the other hand, in rats DOX has a slowly excreted by 
the urine and bile, which promotes the drug deposition in different tissues 
inclusively on the kidneys making them susceptible to injury and toxicity (Lee & 
Harris, 2011; Yesair et al., 1972).  
The main therapeutic actions of DOX is to achieve the cancer cells and to inhibit 
the topoisomerase II, which is an importance enzyme for nucleic acids’ replication 
and transcription, avoiding DNA and RNA synthesis (Chen & Liu, 1994). 
Moreover, DOX has also another mechanism of action, which is the increased 
oxidative stress with further damage to DNA, proteins and cellular membranes 
(Injac & Strukelj, 2008; Shi et al., 2011; Thorn et al., 2011). This drug induces 
high levels of toxicity however the mechanisms of DOX-induce toxicity are not 
fully described and is also poorly understood (El-Moselhy & El-Sheikh, 2014; 
Gurel et al., 2015). There are some speculations about this process, with several 
studies suggesting three physiological mechanisms underlying DOX-induce 
toxicity: oxidative stress, inflammatory activity and apoptosis (Korga et al., 2012; 
Park et al., 2012; Zhang et al., 2009). However, the most acceptable mechanism 
still is the oxidative stress (El-Moselhy & El-Sheikh, 2014).  
Focus on oxidative stress mechanism, DOX is oxidized in an unstable metabolite, 
semiquinone, which is converted again in DOX (Injac & Strukelj, 2008; Thorn et 
al., 2011).  Due to this process, there is an increase of production of reactive 
oxygen species (ROS) with oxidative stress and mitochondrial dysfunction, which 
damage DNA, proteins, and membranes, and promotes ATP depletion. All these 
features contribute to the occurrence of necrosis in different cell types, affecting 
diverse organs (Shi et al., 2011). The oxidative stress and damage are also 
promoted by the increased activation of mitochondrial Matrix Metalloproteins 
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(MMP) (Taskin et al., 2014). By this mechanism, DOX is considered an inducer 
of toxicity in neoplastic and non-neoplastic cells, as in heart, liver, lungs, testis 
and kidneys cells (Thorn et al., 2011; Yasuda et al., 2010).  In the literature, 
several studies report a possible oxidative injury and an increased oxidative 
stress in kidneys after DOX administration. After 24 hours of DOX administration, 
it was observed a decrease of glutathione concentrations, an antioxidant which 
protects the cells from cytotoxic damage, and an increase of lipid peroxidation 
after 4 hours after the drug administration (El-Sheikh et al., 2012). According to 
El-Moselhy and El-Sheikh (2014), the decreased of glutathione content and the 
increased of lipid peroxidation products, after DOX administration, are markers 
of oxidative stress, that can induce toxicity on kidney structure. Oxidative stress 
with oxidative damage of cell components could trigger the apoptotic pathways 
of cell death (Thorn et al., 2011). All this data indicate that inflammation, oxidative 
stress, and cell apoptosis are common processes described in DOX toxicity 
studies, suggesting that they are the main reasons for DOX-induced toxicity. 
 
 
2.2. DOX-induce side-effects  
 
Despite its effectiveness in fighting cancer, therapeutic doses of DOX have many 
side-effects, which can develop during or shortly after treatment or even some 
decades later (Moylan, 2015).  Once the cancer survivors’ quality of life tends to 
decrease due to the DOX-induced toxicity in normal cells (Prylutska et al., 2015), 
its clinical use is limited by the doses (Marques-Aleixo et al., 2016). Indeed, this 
antibiotic has been associated to a number of acute and chronic side-effects (Shi 
et al., 2011).  
Among other, nauseas, vomiting, alopecia, neutropenia, arrhythmias, 
myelosuppression, loss of hearing, mucositis, decrease of blood cell count, 
diarrhea (Injac & Strukelj, 2008), cardiomyopathy, heart failure (Kouzi & Uddin, 
2016), and cardiac dysfunction (Dursun et al., 2011) could be acute side-effects 
that can occur during or within 2-3 days after DOX administration. However, 
mostly of the time, the effects on patients are asymptomatic (Shi et al., 2011). 
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One the other hand, the long-term side-effects are most commonly reported in 
the literature and trends to prevail in time (Kavazis et al., 2016; Polegato et al., 
2015). The long-term side-effects could develop within weeks or months after a 
repetitive and prolonged DOX administration (De Beer et al., 2001; Injac & 
Strukelj, 2008). This drug is known for their toxicity in a variety of organs such as 
heart, liver, lung, kidney, blood cells, and testis (Injac & Strukelj, 2008). However, 
a major chronic side-effect caused by this drug is the cardiotoxicity that has been 
well studied and documented (Moylan, 2015; Scott et al., 2011). It is known that 
this cardiac toxicity is dose-dependent (Kremer et al., 2001).  
.   
 
2.2.1. Side-effects on kidneys 
 
Though, beyond the cardiac toxicity, there are other DOX side-effects that have 
been reported in the literature, such as those resulting from the drug toxicity in 
the kidneys (Hassan et al., 2014). The evidence of kidney toxicity is poorly 
described and understood (Yasuda et al., 2010), however, the studies about this 
side-effect have been increasing.  
In rats, DOX is responsible for inducing nephropathy, heavy proteinuria, 
associated with swelling and vacuolization of epithelial cells. In addition, tubular 
dilatation was also report, as a consequence of kidney damage induced by DOX 
(Injac & Strukelj, 2008). According to Ayla et al. (2011), the kidney damage was 
visible in proximal tubules with a presence of vacuolization in endothelial cell 
cytoplasm, cellular damage and capillary dilatation. The damage on cellular 
membranes, organelles, and genetic material, with lipid peroxidation and protein 
oxidation, were also reported. Furthermore, degenerative changes and 
vacuolization of the endothelial cells with an increased thickness and 
disorganization of glomerular capillary basement membranes were also 
observed. After 8 weeks of DOX administration, a severe inflammatory infiltration 
by neutrophil granulocytes, lymphocytes, and macrophages was described 
(Szalay et al., 2015). 
DOX is one of the drugs responsible for the occurrence of nephrotic syndrome 
(Park et al., 2014), resulting from the damage and apoptosis of podocytes (Tao 
11 
 
et al., 2014), leading to proteinuria and glomerulosclerosis development (Min et 
al., 2016) with further renal failure (Karanovic et al., 2016). Podocytes are an 
important element of the glomerular filtration barrier, so their loss can lead to a 
progressive kidney disease (Zhong et al., 2016). Furthermore, the proteinuria is 
nearly associated with dysfunction of glomerular endothelial cells (Jeansson et 
al., 2009) and the increased permeability of glomerular filtration membrane, 
which is composed of vascular endothelial cells, podocytes, and the glomerular 
basement membrane (Wang et al., 2016). Consequently, this drug decreases 
plasma albumin and the total levels of protein content, increases blood urea 
nitrogen and plasma creatine levels (Lee & Harris, 2011). In rats, the oxidative 
stress on kidney structure is associated with a reduction of glutathione 
concentrations and lower activity of glutathione reductase (Saenko Iu et al., 
2005). Moreover, the collagen deposition in kidney tissue is also a side-effect of 
this drug. The interstitial fibrosis area is higher in rats treated with DOX when 
compared with rats that did not receive the same treatment (Park et al., 2014). 
Of note that, renal fibrosis is a common manifestation of many chronic kidney 
diseases that could result in renal failure (Liu, 2006).  In parallel, some of these 
effects occur also in humans, such as the glomerular damage is similar to human 
focal segmental glomerulosclerosis. So, it is important to better understand the 
mechanisms of DOX toxicity in humans for improving their quality of life after DOX 
treatment. 
 
 
2.3. The benefits of physical exercise practice before, during and 
after DOX treatment 
 
Nowadays, the effectiveness of RPE practiced before, during and/or after cancer 
treatments is well documented (Courneya & Friedenreich, 2007) assuming higher 
importance on improving cancer therapy effects (Yu & Jones, 2016). Exercise is 
considered as a non-pharmacological protection and therapy that prevent and 
attenuated many side-effects causing by a prolonged DOX administration and 
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has a lot of benefits when it is done before, during or even after DOX treatment 
(Scott et al., 2011). 
Several studies investigated the potential of regular exercise practice in cancer 
prevention and concluded that there is an association between the levels of 
physical activity and the decreased risk of having some types of cancer (Brown 
et al., 2012). Moreover, aerobic exercise practice before DOX treatment also has 
protective effects in the development of drug side-effects (Scott et al., 2011). 
Acute exercise 24 hours before the DOX administration has a cardioprotective 
effects observed on end-systolic pressure, left ventricular developed pressure 
and higher maximal rate of ventricular pressure (Wonders et al., 2008). This 
evidence shows the protection of exercise prior treatment against cardiac 
dysfunction induced by DOX, which might be explained by a decreased rate of 
ROS formation.  
During cancer treatment, the RPE practice provides many physiological and 
psychological benefit effects  (Brown et al., 2012). Low-intensity exercise training 
during chronic DOX treatment works as a protector against cardiac toxicity and 
dysfunction, probably by enhancing antioxidant defenses and inhibition of 
cardiomyocytes apoptosis (Chicco et al., 2006). Indeed, endurance training 
seems to improve myocardial tolerance to DOX (Ascensao et al., 2005a). 
Regular exercise practice seems to be also important for cancer survivors and 
exercise could have a therapeutic role instead of a protective one. In fact, the 
benefits of exercise on heart therapy after DOX treatment are well documented. 
After DOX treatment, aerobic exercise seems to attenuate left ventricular 
dysfunction (Scott et al., 2011). 
To our knowledge, there are only a few studies relating the effects of exercise on 
normal kidneys in laboratory animals treated with DOX. In rats, which was 
injected with a single dose of DOX (8.5 mg/kg), it was verified that endurance 
exercise restored the glomerular size and attenuated the collagen deposition 
after running 60 minutes 3 times per week for 13 weeks. A normalization of TGF-
beta, PDGF-BB, p-PDGFR, p-PI3K and p-AKT expressions were also observed 
(Peng et al., 2012b). According to Peng et al. (2012a), sixty minutes of swimming 
seems to have better effects at the renal edema status, collagen levels, 
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decreasing their levels and in the prevention of fibrosis of the glomerular 
mesangium. Moreover, exercise training has also the potential to increase the 
activity of antioxidant system in renal cells (Zeynali et al., 2015), which could 
decrease the oxidative stress, with further attenuation of cellular damage and cell 
death and collagen deposition. According to Chen et al. (2013), on DOX-induced 
kidney chronic disease, a treadmill exercise for 11 weeks, 30 or 60 minutes 3 
times per week, attenuated renal cells’ apoptosis. It might be speculated that if 
the exercise would be done in an early stage of kidney disease it would be 
possible to better control the disease progress.  
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Abstract 
 
This study aimed to verify the effectiveness of regular exercise on the cellular 
damage and collagen deposition in rat kidney induced by a prolonged doxorubicin 
(DOX) administration, mimicking a chemotherapy protocol. Thirty-four male 
Wistar rats were randomly divided into 2 clusters: 1) one treated with DOX (n=17), 
receiving weekly an i.p. injection of 2 mg/kg for 7 weeks and 2) the other treated 
with sterile saline solution (SSS, n=17) that received i.p. injections of vehicle for 
7 weeks. Two weeks after the last injection, five animals from each cluster 
(SSSG, n=5; DOXG, n=5) were euthanized while the remaining rats were 
subsequently divided into sedentary (DOXsedG, n=6; SSSsedG, n=6) and active 
subgroups (DOXactG, n=6; SSSactG, n=6). Active animals were placed 
individually in cages with a run wheel for voluntary running during 2 months, 
whereas sedentary animals were housed individually in conventional cages, with 
movements restricted to the cage space. At the end of the protocol, animals were 
euthanized and kidneys were histologically examined. Comparing to SSSG, 
kidneys from DOXG revealed higher levels of damage, collagen content, and 
increased bowman’s capsule thickness (p<.05). The levels of damage and 
thickness of bowman’s capsule increased on DOXsedG comparing to DOXG 
(p<.05). Comparatively to DOXsedG, the DOXactG presented an overall 
improvement in kidney structure (p<.05), with decreased collagen content and 
thickness of bowman’s capsules. The results allow concluding that voluntary 
running, applied after a prolonged DOX administration, attenuated the long-term 
harmful effects on kidney structure induced by a DOX treatment mimicking a 
chemotherapy protocol.  
 
Keywords: Physical exercise; Renal structure; Tissue damage; Anthracycline; 
Collagen deposition; Nephrotoxicity. 
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Introduction 
  
Doxorubicin (DOX) is an anthracycline antibiotic that since 1960 has been used 
to treat many types of cancers such as leukemia, lymphomas, carcinomas, and 
other solid tumors (Chen et al., 2016; Das et al., 2016; Gu et al., 2015; Mousavi 
et al., 2016; Moylan, 2015), turning out to be one of the most efficient drugs to 
treat adult and pediatric cancers (Lustberg & Zareba, 2016; Mousavi et al., 2016; 
Moylan, 2015). Mitochondria are the main target of this drug’s toxic effects, both 
in neoplastic and normal cells, with a consequent decrease of energy production 
and respiratory efficiency, favoring the occurrence of cellular death (Taskin et al., 
2014). Consequently, beyond the expected toxic effects on neoplastic cells, high 
and repeated doses of DOX can induce non-desirable side effects on patients, 
both in a short and in a long-term in cancer survivors (Wu et al., 2017). Indeed, 
harmful side effects of DOX have been reported for different organs as heart, 
liver, and kidneys (Kumral et al., 2016), which might be explained, among other 
factors, by their content of mitochondria-rich cells. The nephrotoxicity induced by 
DOX is expressed in animals studies by the existence of tubular necrosis (Yilmaz 
et al., 2006) and glomerular atrophy with increased permeability (Kumral et al., 
2016). Glomerular vacuolization, glomerulosclerosis, tubules dilatation with 
cellular atrophy (Chmielewska et al., 2015), and a mild leukocyte infiltrates 
(Kumral et al., 2015) in parallel with the existence of interstitial damage 
(Elsherbiny & El-Sherbiny, 2014), are also described in rats at short and long-
term after DOX administration. Regarding this commitment of interstitial space, 
several animal studies showed that the percentage of collagen deposition 
increased in the kidneys (Egger et al., 2015; Szalay et al., 2015), predominantly 
affecting the renal cortex (Peng et al., 2012b) after DOX treatment.  
Nowadays, physical exercise is regarded as a nonpharmacological therapy for 
cancer diseases (Scott et al., 2011), which can carry many benefits for patients, 
during and after their treatments (Wang et al., 2015). For instance, both in 
humans and animal models, the effectiveness of RPE against DOX-induced 
cardiac injury has been well documented (Kouzi & Uddin, 2016). Similarly, to the 
cardioprotection induced by physical exercise, it would be interesting to observe 
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if RPE could also have similar protective effects on kidneys, especially after a 
prolonged DOX administration mimicking the chemotherapy treatment. To our 
knowledge, just three single studies using animal models showed a favorable 
effect of RPE on renal toxicity induced by DOX, but only after a single dose 
administration of this drug (Chen et al., 2013; Peng et al., 2012a; Peng et al., 
2012b). Indeed, 60 minutes of swimming was effective to restore the renal edema 
status and attenuate the collagen deposition in kidneys, after a single dose (7,5 
mg/Kg) of DOX (Peng et al., 2012a). In the same line, daily physical exercise 
ameliorated the renal cells apoptosis after a single dose (8,5 mg/Kg) of DOX 
(Chen et al., 2013).  Besides, sixty minutes of treadmill exercise improved 
nephropathy induced by a single injection of DOX (8,5 mg/Kg), restoring the 
glomerular size and decreasing the collagen content (Peng et al., 2012b). Based 
on these advantageous results of the RPE obtained with protocols with a single 
dose of DOX, it might be expected that the exercise applied after repeated and 
prolonged administration of the drug, mimicking a chemotherapy treatment, could 
be equally beneficial at short and long-term, for the structure of kidneys. In this 
sense, the aim of this study was to characterize the harmful histological 
repercussions of a prolonged protocol of DOX administration, for 7 weeks, and to 
verify the effectiveness of voluntary running, applied after treatment, to 
revert/attenuate the tissue damage and collagen deposition in Wistar rat kidneys. 
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Material and Methods 
 
Sample and experimental design 
 
Thirty-four male Wistar rats from the Charles River Laboratories, 8 weeks old 
(body weight of 266g ±15,57g) were used in the present study.  
Figure 1: Experimental design.   
 
The body weight of each animal was monitored regularly throughout the 
experimental period, and all interventions were conducted in accordance with the 
recommendations of the National Institute of Health (NIH) Guide for Care and 
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Use of Laboratory Animals. Animals, with free access to rodents’ food and water, 
were kept individually under controlled conditions, with a temperature of 22±1°C 
and 50% of humidity, exposed to an inverted cycle of 12h/12h light/dark. 
After 1 week of quarantine, animals were randomly divided into two clusters: 1) 
the DOX animals (n=17), which received weekly an i.p. injection of doxorubicin 
(2 mg/kg diluted in 0.5 ml sterile saline; D1515 Sigma-Aldrich Co. LLC) for 7 
weeks (with a cumulative dose of 14 mg/kg), and 2) the SSS animals (n=17), 
which received weekly an i.p. injection of sterile saline solution (0.5 ml) for 7 
weeks.   
Two weeks after the last injection, 5 animals were euthanized in each cluster, 
composing the DOXG and SSSG groups for assessment of short-term DOX 
effects. The remaining animals from the initial clusters were subsequently divided 
into sedentary (DOXsedG, n=6; SSSsedG, n=6) and active subgroups 
(DOXactG, n=6; SSSactG n=6). Animals from active groups were individually 
placed in cages equipped with a running wheel allowing for voluntary running 
during two months, whereas the activity of sedentary animals was restricted to 
normal ambulation within their cage space (floor area of 800 cm2 approximately, 
Tecniplast, Buguggiate, Italy). The daily running distance (km) was monitored in 
SSSactG and DOXactG. At the end of the two months period, all animals were 
euthanized. 
 
Euthanasia and renal sample processing  
 
Animals were anesthetized with an i.p. injection of Xylazine (20mg/kg) and 
Ketamine (80mg/kg), weighed, and further euthanized by exsanguination. After 
laparotomy, both kidneys from each animal were excised, quickly washed in 
saline buffer, superficially dried, and weighed. The kidneys’ relative body weight 
was calculated based on the formula: kidneys’ weight x100%/body weight. 
From each animal, small pieces of 5 mm3 from both kidneys were fixed with 4% 
paraformaldehyde (0.1M PBS, pH of 7.2-7.4, with 2.5% w / v sucrose, and 0.1% 
glutaraldehyde) during 24 hours at 4ºC. These samples were then washed in PBS 
(0.1M, pH of 7.2-7.4) and dehydrated through graded ethanol solutions, cleared 
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in xylene and mounted in paraffin according to routine histological protocols. 
Sections of 5 µm were cut from paraffin blocks on a microtome (Leica 
Microsystems, Model RM2125) with a disposable stainless steel blade (Leica 
Microsystems, Model 819), floated onto warm water (42–44 ºC), and mounted on 
silane-coated slides (Sigma, S4651-72EA). After dewaxing with xylene and 
rehydration with graded alcohol, slides were stained with hematoxylin/eosin or 
with Picrosirius Red, as described elsewhere (Moreira-Gonçalves et al., 2015), 
and examined in a light microscope (LM) (Carl Zeiss Imager A1 Axio) with a 
magnification of 400x.  
 
Morphological evaluation 
 
Semi-quantification of kidney damage: for each group, more than 30 tissue 
sections were analyzed in a blind fashion to evaluate the severity of the following 
parameters: i) cellular degeneration, ii) interstitial inflammatory cell infiltration, iii) 
necrotic zones, and iv) alteration of tissue organization (Ascensao et al., 2005b). 
The severity of cellular degeneration was scored according to the number of cells 
showing any alterations (dilatation, vacuolization, pyknotic nuclei, and 
eosinophilic cells) within the complete LM visual field: grade 0 = no change from 
normal; grade 1 = a limited number of isolated cells (until 5% of the total cell 
number); grade 2 = groups of cells (5–30% of cell total number); and grade 3 = 
diffuse cell damage (30% of total cell number). The Inflammatory activity was 
graded into: grade 0 = no cellular infiltration; grade 1 = mild leukocyte infiltration 
(1 to 3 cells per visual field); grade 2 = moderate infiltration (4 to 6 leukocytes per 
visual field); and grade 3 = heavy infiltration by neutrophils. The necrotic level 
was assessed as: grade 0 = no necrosis; grade 1 = dispersed necrotic foci; grade 
2 = confluent necrotic areas; and grade 3 = massive areas of necrosis. The 
severity of tissue disorganization was scored according to the percentage of the 
affected tissue: score 0 = normal structure; score 1 = less than one-third of tissue; 
score 2 = more than one-third and less than two-thirds; score 3 = more of two-
thirds of tissue. Since the total score was calculated by the sum of each score 
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parameter, the highest possible score for each section analyzed was 12 and the 
lowest was 0. 
 
Assessment of fibrous tissue accumulation: All 204 images from all groups 
stained with Picrosirius Red were analyzed with Image Pro Plus 6.0 software 
(Media Cybernectics, Inc). The area occupied by collagen (stained red) within the 
kidney tissue was quantified for each visual field and expresses in % following 
the methodology described elsewhere (Moreira-Gonçalves et al., 2015).  
 
Assessment of Bowman's capsule thickness: To measure the thickness of the 
glomerular capsule, the Image J Software 1.50i (National Institute of Health, USA) 
was used with a microscale. In each animal, more than 68 Bowman’s Capsules 
were measured on the slides stained with Picrosirius Red. The thickness of 
capsules was measured in two randomly selected sites, and all values 
(expressed in µm) obtained were averaged for each slide. 
 
Statistical analysis  
 
The Kolmogorov-Smirnov test allowed investigating within-group normality for the 
variables. Shapiro-Wilk test was only performed to analyze the normality of the 
body weight, kidney weight, and relative kidney weight variables. The variables 
with a normal distribution (values of a total of collagen content, bowman’s capsule 
thickness, body weight, kidney weight and relative kidney weight) were treated 
with parametric tests, using multifactorial ANOVA (DOX x Time x Exercise). The 
non-parametric Kruskal-Wallis test was used in variables without normal 
distribution (Semi-quantification of kidney damage). Results of all parametric data 
are presented as mean ± standard deviation (SD) and of non-parametric data are 
presented as median (interquartile range). IBM SPSS Statistics 23.0 was used 
and differences were considered significant with a p<.05. 
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Results 
 
Sample characterization and voluntary running performed 
 
Table 1 depicts the animals’ body weight at sacrifice as well as the kidneys’ 
absolute and relative body weights. The total running distance performed by 
SSSactG and DOXactG groups is also shown in table 1. 
The repeated administration of DOX affected, in a short-term (DOXG vs. SSSG), 
the normal growth of the animals, shown by the lower body weight of DOXG 
(p<.05), without affecting the absolute and relative kidneys weight (p>.05). 
However, although the absence of significant differences between DOXG and 
SSSG, an apparent trend to increase kidney volume on DOXG was observed 
(p=0.113).  
In long-term, the administration of DOX also promoted higher body weight in 
sedentary animals (DOXG vs. DOXsedG, p<.05) without affecting the kidneys 
absolute and relative weight.  
The voluntary running distance was not different between DOXactG and 
SSSactG (p>.05), suggesting that the ability to perform physical work was not 
compromised by DOX treatment. 
 
Kidney damage  
 
Data in Table 2 shows the kidney histological alterations, illustrating the toxic 
effects of DOX at short (SSSG vs. DOXG) and long-term (DOXG vs. DOXsedG). 
The favorable effects of voluntary running on DOX-induced long-term toxicity are 
also shown in Table 2 (DOXactG vs. DOXsedG). 
Kidneys from animals of SSSG, SSSsedG, and SSSactG showed, in general, a 
preserved structure, although the presence of some minor and punctual 
alterations (Fig.1) more notorious in SSSsed animals (p<.05 SSSG vs. 
SSSsedG), which were not attenuated by voluntary running (p>.05 SSSsedG vs. 
SSSactG).  
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The short-term DOX toxicity was expressed by signals of cellular degeneration 
(p<.05 DOXG vs SSSG), mainly detected by cytoplasmic vacuolization, 
eosinophilic cells and pyknotic nuclei, especially affecting the proximal tubules 
(Fig.1). In these convoluted tubules, the presence of necrotic areas with leukocyte 
infiltration were also frequent in DOXG (p<.05 vs. SSSG). In DOXG, the loss of 
tissue organization was notorious by an increased level of vascular congestion, 
by an apparent general changing of the glomerular structure, and by the presence 
of interstitial edema (Fig.1), characterized by the increased space between 
nephron convoluted tubules (p<.05 DOXG vs SSSG). Many cellular debris were 
visible within the proximal and distal convoluted tubules. The total score of tissue 
damage was higher in DOXG group (p<.05 DOXG vs SSSG).  
At the long-term point of view, as shown in Table 2, the level of necrotic areas, 
tissue disorganization and the total score of tissue damage increased in 
DOXsedG comparatively to DOXG (p<.05). In DOXsedG, the existence of 
fibrinoid material and cellular debris inside dilated convoluted tubules (Fig.1), and 
a great amount of conjunctive tissue proliferation in the interstitial space were 
histological characteristics commonly observed.  
Although presenting similar kidney structural alterations as DOXsedG (Figs. 2 & 
3), the levels of cellular degeneration, necrosis, inflammation, tissue 
disorganization, and total score of tissue damage were significantly reduced in 
DOXactG (Table 2), suggesting that voluntary running attenuated the long-term 
kidney damage induced by DOX treatment (p<.05 DOXsedG vs DOXactG).  
 
Collagen deposition and Bowman’s capsule thickness 
 
Figure 4 depicts the percentage of total collagen content in all studied groups. 
DOX-induced an increase of the percentage of collagen content, at short-term 
(p<.05 DOXG vs SSSG), without significant variations at long-term (p>.05 DOXG 
vs DOXsedG). Of note that voluntary running attenuated the collagen deposition 
on DOXactG (p<.05 DOXactG vs. DOXsedG). One the other hand, the 
percentage of collagen content was higher on DOXactG comparing to SSSactG 
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(p<.05), suggesting that voluntary running does not entirely repair/revert the 
collagen deposition promoted by DOX.   
Figure 5 represents the bowman’s capsule thickness in all groups. A significant 
increase in this parameter was observed at short (p<.05 SSSG vs DOXG) and 
long-term (p<.05 DOXG vs DOXsedG) after DOX treatment. It must be 
highlighted that voluntary running decreased the TBC in animals treated with 
DOX (p<.05 DOXsedG vs DOXactG).  
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Discussion 
 
The obtained results clearly show the harmful effects of DOX administration 
mimicking a chemotherapy treatment on kidney structure, expressed by 
histological alterations after two weeks the last injection of DOX, with a 
progressive aggravation over time and with enhancement of collagen content. Of 
note that these injuries are very similar to those already described in humans 
after DOX treatment (Turnberg et al., 2006), suggesting analogous 
pathophysiological mechanisms, among which might be oxidative stress (Abo-
Salem et al., 2009). If this was the picture in sedentary animals, in active animals 
the structural alterations were partially attenuated.  
 
Short-term DOX toxic effects 
 
Regarding the control animals, treated with SSS, they showed, in general, 
kidneys with a preserved morphological structure, although the existence of some 
punctual and disperse alterations, mainly expressed by cellular vacuolization in 
proximal tubules, which can be explained by the functional wear and/or even by 
the histology technical procedures. In opposition, animals treated with DOX 
increased their body weight and revealed an altered kidney structure with signals 
of cellular degeneration, necrosis, inflammation, with a general increase of 
collagen deposition and the TBC.  
At short-term, the damage induced by DOX mainly affected the cells of proximal 
convoluted tubules, which might be explained, among other factors, by their 
richness in mitochondrial content, the main target organelle of this drug (Su et al., 
2015). In these proximal tubular cells, it is described that DOX activate caspase-
3 through the mitochondrial pathway, triggering apoptosis (Su et al., 2015). Of 
note that these histological abnormalities are in accordance with the already 
described in the literature, with several works highlighting the glomerular and 
tubular damage induced by DOX, with degenerative changes and vacuolization 
on cytoplasm of proximal tubules’ cells, but also affecting glomeruli (Ayla et al., 
2011; Sadek et al., 2016; Zickri et al., 2012). The renal injury might initially be 
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triggered by an enhanced mitochondrial reactive oxygen species production 
(Abo-Salem et al., 2009), followed by an inflammatory response with infiltrating 
inflammatory cells induced by DOX (Liu et al., 2016; Sadek et al., 2016). One the 
other hand, in several cortical regions, a local tubular dilatation was mainly 
observed in distal tubules, with their lumen fulfilled with hyaline material and 
cellular debris, suggesting the occurrence of tubular obstruction probably 
motivated by protein precipitation and deposition of debris derived from upstream 
cellular necrosis affecting proximal tubules. Even after two weeks the last DOX 
injection, a slight increase of collagen content was already observed in interstitial 
space, affecting kidney cortex and medullary areas. This extensive fibrosis might 
be due to the DOX-induced enhanced production of transforming growth factor 
beta (TGF-β) (Ren et al., 2016), a cytokine mainly produced by renal tubular 
epithelial cells and interstitial cells (Li et al., 2006), which plays a central role in 
the progression of the tubular epithelial-mesenchymal transition in renal fibrosis-
inducing extracellular matrix deposition (Ren et al., 2016). The occurrence of a 
continuous inflammatory tissue reaction, favoring the movement of proteins from 
the vascular space to the interstitium with the formation of a fibrin network, may 
also contribute, directly or indirectly, to the observed general renal fibrosis (Liu, 
2011). Massive fibrosis avoids the integral reconstruction and functionally of 
tissue and organs. Of note that, inflammation and fibrosis are critical roles of renal 
diseases (Pohlers et al., 2009). In addition, DOX was also responsible for 
increasing the TBC comparatively with SSSG, may be by the general activation 
of collagen production or due to the high mechanic tension on the glomeruli.  
 
Voluntary running attenuates long-term DOX toxic effects 
 
At long-term, the body weight of animals increased on DOXsedG group, even 
without affecting the work capacity as expressed by the absence of significant 
differences in running distance between SSactG and DOXactG. The damage 
induced by DOX on DOXsedG was more evident and aggravated comparatively 
to DOXG. After two months of last DOX administration, a more accentuated and 
dispersed tubular dilatation, with lumen fulfilled with hyaline material and cellular 
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debris were found. This alteration was also described in recent studies, however, 
only a single injection of DOX was applied in rat models (El-Moselhy & El-Sheikh, 
2014; Sadek et al., 2016). The aggravation with time of the lesions initially found 
in DOXG suggests the existence of an active pathophysiological process that 
does not finish with the end of DOX treatment. Moreover, the signals of an active 
inflammatory reaction observed in DOXsedG reinforce this suggestion. 
Nevertheless, the levels of collagen content remained similar to those observed 
in DOXG. Although kidney functionality was not assessed in our study, it is known 
that large amounts of collagen content are associated with renal dysfunction and 
failure (Ren et al., 2016; Sadek et al., 2016). Even without long-term aggravation 
of fibrosis, the TBC on sedentary group increased comparing to DOXG group, 
highlighting the long-term renal toxicity induced by DOX. Once the collagen 
content did not increase at long-term, the speculation of general activation of 
conjunctive tissue production maybe is not the most acceptable theory. While, in 
DOXsedG group high deposition and an increased of the debris inside the tubules 
was visible, which could explain the higher tension on glomeruli. Debris 
deposition may clog the tubules preventing the blood circulation and rise the 
thension, as result of this tension the TBC increased. 
In the current study, the active group treated with DOX, compared with sedentary 
group, showed reduced levels of cellular degeneration, inflammatory activity, 
necrosis and tissue disorganization; moreover, DOXsedG evidenced a 
decreased collagen deposition and bowman’s capsule thickness. However, a 
total reversing and restoring of kidney normal structure was not verified. Voluntary 
running attenuated kidney damage on DOXactG, probably due to the benefits of 
exercise on the immune system (Miyagi et al., 2014), improving cell defenses. 
Therefore, this immune system protection through the exercise, reduce the 
apoptotic cells levels. In addition to the last point, the enhancement of 
vascularization and the existence of lower levels of cytokines after RPE practice 
could explain, at least in part, the decrease the inflammatory response observed 
in these animals. Moreover, the decrease of cytokines levels also allows to 
regulate the antioxidant defense system (Zeynali et al., 2015) not compromising 
the renal function. Among the other cytokines, exercise also normalized the 
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expression of TGF-β (Peng et al., 2012b) reducing the inflammatory process 
suggesting a lower collagen deposition on kidneys. The reduction of Bowman’s 
capsule thickness observed in DOXactG can be explained by a lower glomerular 
filtration tension and also by the lower collagen deposition. After RPE practice, 
all these physiological benefits on kidneys, allow to prevent or/and reduce the 
toxic effects induced by this drug. However, the mechanisms of the exercise 
protection on kidney toxicity induced by DOX are poorly understood. In humans, 
is possible to verify the same structural changes after a prolonger DOX 
administration (Peng et al., 2012b; Sadek et al., 2016). Fortunately, exercise 
could improve kidney function in humans by improving metabolic factors 
(Moinuddin & Leehey, 2008).  
In conclusion, DOX has a severe toxic side effects even short or long-term. 
Although, two months of voluntary running could be considered as favorable to 
ameliorate this side effects induced by DOX. Based on these results, the 
prescription of RPE for cancer survivors must be considered to attenuate the side 
effects of the treatments. However, more studies are needed to explain the 
mechanisms of DOX-induce nephrotoxicity as well as the mechanisms of 
protection promoted by regular exercise. 
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Table 1: Values (presented as mean±standard deviation) of body weight and kidney absolute and 
relative weight from all groups, and total running distance performed by active groups.  
  
Sterile Saline Solution Doxorubicin 
SSSG SSSsedG SSSactG DOXG DOXsedG DOXactG 
Body  
Weight (g) 
386.4 
±29.70 a 
434.7 
±57.46  
422.7 
±29.70 
312.8 
±58.32 b 
393.8 
±74.62  
363.2 
±46.61  
Kidney Weight (g) 
2.1 
±0.68 
2.3±0.20  2.3±0.40  2.0±0.34 2.4±0.55   2.5±0.82 
Relative Kidney Weight 
(%) 
0.5±0.16 0.5±0.08  0.5±0.07 0.7±0.22  0.6±0.08 0.7±0.17  
Total running distance 
(Km) 
- - 23.9±6.99 - - 30.5±19.84 
Notes: SSSG- Group Sterile saline solution; SSSsedG- Group Sterile saline solution sedentary; 
SSSactG- Group Sterile saline solution active; DOXG- Group Doxorubicin; DOXsedG- Group 
Doxorubicin sedentary; DOXactG- Group Doxorubicin active.  
a p‹0,05 vs DOXG;  
b p‹0,05 vs DOXsedG 
 
 
Table 2: Values (presented as a Median (Interquartile Range)) of histologic alterations used to 
assess kidney damage in all groups. 
Notes: SSSG- Sterile saline solution group; DOXG- Doxorubicin group; SSSsedG- Sterile saline 
solution sedentary group; DOXsedG- Doxorubicin sedentary group; SSSactG- Sterile saline 
solution active group; DOXactG- Doxorubicin active group. 
a p<.05 vs. SSSG 
b p<.05 vs. DOXsedG 
c p<.05 vs. DOXG 
d p<.05 vs. DOXactG 
 SSSG DOXG SSSsedG DOXsedG SSSactG DOXactG 
Cellular Degeneration 0(1)   3(1) a  1(1) b 3(1)   0(1) d 1(1) b  
Necrosis 0(0)  2(1) a 1(1) b 3(1) c 0(1) d 1(1) b 
Inflammatory Activity 0(0)  2.50(1) a 1(1) a b 3(1)  0(1) d 1(1) b 
Tissue Disorganization 0(1)  2(0) a 1(1) b 3(0) c 0(1) d 1(1) b 
Total Score 1(1)  10(2) a 2(0) a b 11(3) c 2(1) d 5(1) b 
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Figure 2: Representative photomicrographs stained with hematoxylin and eosin of kidneys from 
group sterile saline solution (SSSG), group sterile saline solution sedentary (SSSsedG), group 
sterile saline solution active (SSSactG), group doxorubicin (DOXG), group doxorubicin sedentary 
(DOXsedG), and group doxorubicin active (DOXactG). On DOXG a large amount of necrotic cells 
was verified; interstitial edema was observed on DOXsedG and DOXactG; and tubular dilatation 
with hyaline deposition on DOXsedG. 
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Figure 3: Representative photomicrographs stained with hematoxylin and eosin of kidneys from 
group sterile saline solution (SSSG), group sterile saline solution sedentary (SSSsedG), sterile 
group saline solution active (SSSactG), group doxorubicin (DOXG), group doxorubicin sedentary 
(DOXsedG), and group doxorubicin active (DOXactG). On DOXG was verified the existence of 
edema (Yellow arrow) and vacuolated cells (Black arrow).  A deposition of hyaline (Black arrow), 
a distal tubular dilatation (Red arrow) and conjunctive tissue (White arrow) was observed on 
DOXsedG. In DOXactG the hyaline content in tubules (Black arrow) was less than the last group, 
while were also found tubular dilatation (Red arrow). It is noted the conjunctive tissue around the 
tubules (White arrow) and vascular congestion (Yellow arrow). 
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Figure 4: Values (presented as mean±standard deviation) of the percentage of total collagen 
deposition in kidney area in group sterile saline solution (SSSG), group sterile saline solution 
sedentary (SSSsedG), group sterile saline solution active (SSSactG), group doxorubicin (DOXG), 
group doxorubicin sedentary (DOXsedG), and group doxorubicin active (DOXactG).  
 
Figure 5: Values (presented by mean standard deviation) of thickness of the Bowman’s capsules 
of the kidneys in group sterile saline solution (SSSG), group sterile saline solution sedentary 
(SSSsedG), group sterile saline solution active (SSSactG), group doxorubicin (DOXG), group 
doxorubicin sedentary (DOXsedG), and group doxorubicin active (DOXactG).  
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4. Main Conclusions  
 
Assuming the proposed goals on the first chapter, at short-term DOX was 
responsible for induced: 
• Renal damage 
• An Increased collagen deposition  
• An increase of TBC  
 
While, at long-term: 
• Increased renal damage 
• Increased the TBC 
 
One the other hand, regular voluntary running was responsible for attenuated the 
side-effects induced by DOX: 
• Ameliorated kidney damage 
• Decreased collagen content 
• Decreased the TBC 
 
The results are in line with our previews hypotheses. DOX-induced side-effects 
such as renal damage, increase collagen deposition and the TBC at short-term 
and in long-term only aggravated renal damage and increased the Bowman’s 
capsule thickness. However, regular voluntary running could be used as a 
therapy to attenuate the harmful effects caused by a prolonged DOX 
administration, improving renal structure and function. 
 
Despite these results, as a suggestion for future studies, more studies are needed 
to understand the mechanisms of DOX-induced kidney toxicity and which 
physiological mechanisms are underlying of physical exercise to attenuate the 
renal toxicity induced by DOX.  
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